Biological Products, (No Diagnostic Substances) · CIK 1382101
Developing site-specific antibody drug conjugates for oncology using proprietary cell-free protein synthesis platforms
Comparable business profile · signals at a glance
In the 90 days to Oct 15, 2025: 5 insiders bought $90K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2025 | Matsui ConnieDirector | Buy | 50,000 | $0.80 | $40K |
| Oct 15, 2025 | Chow Gregory K.CFO | Buy | 19,750 | $0.81 | $16K |
| Oct 15, 2025 | Gerber Hans-PeterCHIEF SCIENTIFIC OFFICER | Buy | 17,000 | $0.80 | $14K |
| Oct 15, 2025 | Pauling DavidChief Admin. Ofcr. & GC | Buy | 12,504 | $0.80 | $10K |
| Oct 15, 2025 | Chung JaneChief Executive Officer | Buy | 12,500 | $0.80 | $10K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.